SEREVENT DISKUS is a Oral; Respiratory (inhalation) Powder, Metered in the Human Prescription Drug category. It is labeled and distributed by Dispensing Solutions, Inc.. The primary component is Salmeterol Xinafoate.
| Product ID | 68258-8961_198f20a2-218e-4a0f-a4c1-ae7c3b62e1c6 |
| NDC | 68258-8961 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SEREVENT DISKUS |
| Generic Name | Salmeterol Xinafoate |
| Dosage Form | Powder, Metered |
| Route of Administration | ORAL; RESPIRATORY (INHALATION) |
| Marketing Start Date | 1997-11-25 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020692 |
| Labeler Name | Dispensing Solutions, Inc. |
| Substance Name | SALMETEROL XINAFOATE |
| Active Ingredient Strength | 50 ug/1 |
| Pharm Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 1997-11-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020692 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1997-11-25 |
| Inactivation Date | 2019-11-13 |
| Ingredient | Strength |
|---|---|
| SALMETEROL XINAFOATE | 50 ug/1 |
| SPL SET ID: | c4925b2c-bde1-45fd-8109-dc75bee3b7a3 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0173-0520 | SEREVENT | salmeterol xinafoate |
| 0173-0521 | SEREVENT | salmeterol xinafoate |
| 68258-8961 | SEREVENT | salmeterol xinafoate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SEREVENT 73694169 1628891 Live/Registered |
GLAXO GROUP LIMITED 1987-11-09 |